COVID vaccine uptake low in young US kids in first months of availabilityThe Centers for Disease Control and Prevention (CDC) said COVID-19 vaccine uptake among children 5 to 11 years old in the United States remained low during the first 11 weeks of vaccine eligibility, especially in high social vulnerability index (SVI) areas.
The research was published today in Morbidity and Mortality Weekly Report (MMWR).The Pfizer-BioNTech was approved for emergency use in 28 million eligible children ages 5 to 11 on Oct 29, 2021.
Ninety-two percent of eligible children lived within 5 miles of an active vaccine providers within 1 month of vaccine availability.
As of Jan 18, 2022, 39,786 providers had administered 13.3 million doses.First-dose coverage at 4 weeks after launch was 15.0% (10.5% and 17.5% in high and low SVI areas, respectively; rate ratio [RR], 0.68; 95% confidence interval [CI] 0.60 to 0.78), and at 11 weeks was 27.7% (21.2% and 29.0%; RR, 0.76; 95% CI, 0.68 to 0.84), the authors said.Vaccination series completion rate was 19.1% (13.7% and 21.7%; RR, 0.67; 95% CI, 0.58 to 0.77).